Puberty blockers stunted the height and impaired the bone mass density of children wishing to change gender, researchers have found.
Until recently puberty blockers were billed as a “fully reversible” treatment that paused the physical transformation of puberty, but the NHS has since updated its guidance to say the long-term impact on brains and bones is unknown.
The Gender Identity Development Service (GIDS) suspended the treatment for children in November, after the High Court found it was “unlikely” that under-16s could give informed consent to drugs that may impair their future fertility and sexual function.
Source: Puberty blockers ‘stunt bone growth of children’ | News | The Times